| Alyssa Easter, MD | |
|
3800 S National Ave Ste 700, Springfield, MO 65807-5279 | |
| (417) 269-8817 | |
| (417) 269-8744 |
| Full Name | Alyssa Easter |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 5 Years |
| Location | 3800 S National Ave Ste 700, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265882120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2017034295 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocates For A Healthy Community Inc | 5395653562 | 34 |
News Archive
The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
› Verified 5 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871786905 PECOS PAC ID: 5092624320 Enrollment ID: O20040129000626 |
News Archive
The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
› Verified 5 days ago
| Entity Name | Advocates For A Healthy Community Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558303057 PECOS PAC ID: 5395653562 Enrollment ID: O20041109000631 |
News Archive
The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
› Verified 5 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Easter, MD 3800 S National Ave Ste 700, Springfield, MO 65807-5279 Ph: (417) 269-8817 | Alyssa Easter, MD 3800 S National Ave Ste 700, Springfield, MO 65807-5279 Ph: (417) 269-8817 |
News Archive
The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
› Verified 5 days ago
Shalvinder Kaur Seehra, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3525 E Battlefield St, Springfield, MO 65809 Phone: 417-269-1499 Fax: 417-269-1459 | |
Harwinder K Dhanoa, Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Evergreen St, Springfield, MO 65803 Phone: 417-823-2900 | |
Thomas E Dahlberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3322 S Campbell Ave Ste T-1, Springfield, MO 65807 Phone: 417-220-4480 Fax: 417-414-0017 | |
Dr. John H Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 280, Springfield, MO 65807 Phone: 417-885-0834 Fax: 417-888-6763 | |
Dr. Jay L Sparks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 220, Springfield, MO 65807 Phone: 417-820-7450 Fax: 417-820-7455 | |
Dr. Conrad Mitchell Bajor, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2600 | |
Dr. William Russell Detten, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1530 E Republic Rd, Springfield, MO 65804 Phone: 417-269-1362 Fax: 417-269-1372 |